Structural and Functional Characterization of the SUMO

Total Page:16

File Type:pdf, Size:1020Kb

Structural and Functional Characterization of the SUMO Structural and Functional Characterization of the SUMO Proteases SENP6 and SENP7 Kamela Olivya Alegre Universitat Autonoma de Barcelona 1 “There are two ways you can live your life. One is as though nothing is a miracle. The other is as though everything is a miracle.” Albert Einstein 2 3 Structural and Fumctional Analysis of the SUMO Proteases SENP6 and SENP7 Doctoral thesis presented by Kamela Olivya Alegre for the degree of PhD in Biochemistry from the University Autonomous of Barcelona Institute of Biotecnology and Biomedicine, Protein Structure laboratory. Thesis supervised by Dr. David Reverter. 4 Kamela Alegre David Reverter 5 INDEX Abbreviations ............................................................................................................................................ 1-2 General Introduction .............................................................................................................................. 3-44 The Ubiquitin System: Ubiquitin and Ubiquitin-like Proteins ...............................................................5 Introduction to ubiquitin ................................................................................................................5 Mechanism and enzyme cascade ....................................................................................7 Ubiquitin conjugation machinery ...................................................................................9 Introduction to SUMO ..................................................................................................................13 SUMO conjugation machinery ......................................................................................16 SUMO isoforms ...............................................................................................................19 Cellular functions ............................................................................................................19 Lysine-linked chains .......................................................................................................23 Introduction to Ubiquitin and SUMO Isopeptidases ...............................................................27 The SENPs – SENtrin-specific family of Proteases ..................................................................................... 34 SENP1 and SENP2 .........................................................................................................................34 SENP3 and SENP5 .........................................................................................................................40 SENP6 and SENP7 .........................................................................................................................42 Objectives .....................................................................................................................................................47 Experimental Procedures ...........................................................................................................................51 Protein production and purification .........................................................................................................51 Protein constructs ..........................................................................................................................52 SENP7 .............................................................................................................................. 52 SENP2 .............................................................................................................................. 52 SENP6 ...............................................................................................................................53 6 SUMO .............................................................................................................................. 55 RanGAP1 ..........................................................................................................................56 SUMOylation reaction ..................................................................................................................57 RanGAP1-SUMO1 and RanGAP1-SUMO2 ................................................................ 57 diSUMO2 and diSUMO2/1 ...........................................................................................57 Biochemical assays .......................................................................................................................................58 C-terminal hydrolase activity ......................................................................................................58 Deconjugation activity ..................................................................................................................59 Initial rate velocities ......................................................................................................................60 Michaelis-Menten steady-state kinetics .....................................................................................60 Loop3 characterization ................................................................................................................................61 NMR ................................................................................................................................................61 Circular dichroism .........................................................................................................................61 Infrared spectral analysis .............................................................................................................61 Limited proteolysis .......................................................................................................................62 N-terminal sequencing .................................................................................................................62 Mass spectromer analysis .............................................................................................................62 Complex preparation ..................................................................................................................................62 Complex formation/purification via gel filtration .................................................................................63 Results ...........................................................................................................................................................67 Swapping the SUMO isofrom specificity of SENP6/7 ............................................................67 SENP6 is SUMO2/3-specific and inefficient at SUMO processing .........................67 Model for SENP6/7 interaction with SUMO2/3 and identification of interface residues ..............................................................................................69 Swapping SUMO1 and SUMO2 residues in processing reaction ..............71 Swapping SUMO1 and SUMO2 residues in RanGAP1-SUMO in deconjuation reaction .......................................................................................72 7 Swapping SUMO1 and SUMO2 residues in diSUMO2 in deconjugation reaction ...............................................................................................................74 SENP6 loop deletion mutants .........................................................................75 Steady-state kinetic analysis of SUMO1 mutants ........................................79 Loop1 SENP6/7 is responsible for SUMO interface specificity .............................................82 Structure of Loop1 ............................................................................................82 Mutagenic analysis of SENP7 Loop1 .............................................................83 SENP7 Loop1 interaction with SUMO2 ........................................................86 SENP2 Loop1 insertion is highly reactive against diSUMO2 ....................88 Complexes with substrates ..........................................................................................................90 Processing complexes ......................................................................................90 Deconjugation complexes ................................................................................91 SENP63CS forms a stable complex with diSUMO2 ..................................91 SENP623CS forms a stable complex with diSUMO2 ..............................93 SENP2CS forms a stable complex with diSUMO2 ......................................95 Characterization of SENP6 Loop3 ..................................................................97 DISCUSSION ............................................................................................................................................107 BIBLIOGRAPHY ......................................................................................................................................125 CONCLUSIONS .......................................................................................................................................141 APPENDIX .................................................................................................................................................143 8 Alegre, K. O., Reverter, D. (2011). “Swapping the Small Ubiquitin-like Modifier (SUMO) Isoform Specificity of SUMO Proteases SENP6 and SENP7” J Biol Chem 41, 36142-51. ....145 Summary SENP Activities .........................................................................................................157
Recommended publications
  • Bayesian Hierarchical Modeling of High-Throughput Genomic Data with Applications to Cancer Bioinformatics and Stem Cell Differentiation
    BAYESIAN HIERARCHICAL MODELING OF HIGH-THROUGHPUT GENOMIC DATA WITH APPLICATIONS TO CANCER BIOINFORMATICS AND STEM CELL DIFFERENTIATION by Keegan D. Korthauer A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Statistics) at the UNIVERSITY OF WISCONSIN–MADISON 2015 Date of final oral examination: 05/04/15 The dissertation is approved by the following members of the Final Oral Committee: Christina Kendziorski, Professor, Biostatistics and Medical Informatics Michael A. Newton, Professor, Statistics Sunduz Kele¸s,Professor, Biostatistics and Medical Informatics Sijian Wang, Associate Professor, Biostatistics and Medical Informatics Michael N. Gould, Professor, Oncology © Copyright by Keegan D. Korthauer 2015 All Rights Reserved i in memory of my grandparents Ma and Pa FL Grandma and John ii ACKNOWLEDGMENTS First and foremost, I am deeply grateful to my thesis advisor Christina Kendziorski for her invaluable advice, enthusiastic support, and unending patience throughout my time at UW-Madison. She has provided sound wisdom on everything from methodological principles to the intricacies of academic research. I especially appreciate that she has always encouraged me to eke out my own path and I attribute a great deal of credit to her for the successes I have achieved thus far. I also owe special thanks to my committee member Professor Michael Newton, who guided me through one of my first collaborative research experiences and has continued to provide key advice on my thesis research. I am also indebted to the other members of my thesis committee, Professor Sunduz Kele¸s,Professor Sijian Wang, and Professor Michael Gould, whose valuable comments, questions, and suggestions have greatly improved this dissertation.
    [Show full text]
  • SENP Proteases As Potential Targets for Cancer Therapy
    cancers Review SENP Proteases as Potential Targets for Cancer Therapy Paulina Tokarz * and Katarzyna Wo´zniak Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-42-635-48-15; Fax: +48-42-635-44-84 Simple Summary: Post-translational modification—the biochemical addition of functional groups or proteins—occurs following protein biosynthesis and contributes to an increase in the functional diversity of the proteome. Post-translational modifications include SUMOylation—the covalent attachment of small ubiquitin-related modifier (SUMO) proteins to substrate proteins. SUMOylation is a reversible modification, which is erased by SUMO-specific proteases (SENPs). Deregulation of SENPs leads to cellular dysfunction and is associated with various diseases, including cancer. The role of SENPs in cancer pathogenesis is expected, and thus these proteins are considered promising targets for drug design and development. In this review, we will discuss the role of SENPs, focusing on DNA repair and the cell cycle—cellular pathways malfunctioning in most cancer cells—and provide an update on advances in the development of SENP-oriented inhibitors. Abstract: SUMOylation is a reversible post-translational modification (PTM) involving a covalent attachment of small ubiquitin-related modifier (SUMO) proteins to substrate proteins. SUMO-specific proteases (SENPs) are cysteine proteases with isopeptidase activity facilitating the de-conjugation of SUMO proteins and thus participating in maintaining the balance between the pools of SUMOylated and unSUMOylated proteins and in SUMO recycling. Several studies have reported that SENPs’ aberrant expression is associated with the development and progression of cancer.
    [Show full text]
  • Distinct Basket Nucleoporins Roles in Nuclear Pore Function and Gene Expression
    bioRxiv preprint doi: https://doi.org/10.1101/685263; this version posted June 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. Distinct Basket Nucleoporins roles in Nuclear Pore Function and Gene Expression: Tpr is an integral component of the TREX-2 mRNA export pathway Vasilisa Aksenova1, Hang Noh Lee1, †, Alexandra Smith1, †, Shane Chen1, †, Prasanna Bhat3, †, James Iben2, Carlos Echeverria1, Beatriz Fontoura3, Alexei Arnaoutov1 and Mary Dasso1, * 1Division of Molecular and Cellular Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. 2Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20879 3Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. † These authors contributed equally to this work. *Correspondence: [email protected]. Acronyms: NPC – nuclear pore complex; BSK-NUPs – basket nucleoporins; NG – NeonGreen; AID - Auxin Inducible Degron 1 bioRxiv preprint doi: https://doi.org/10.1101/685263; this version posted June 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. Abstract Nuclear pore complexes (NPCs) are important for many processes beyond nucleocytoplasmic trafficking, including protein modification, chromatin remodeling, transcription, mRNA processing and mRNA export.
    [Show full text]
  • Rangap1 Induces Gtpase Activity of Nuclear Ras-Related Ran (Gtpase-Activating Protein/Rccl/TC4/G2 Checkpoint) F
    Proc. Nati. Acad. Sci. USA Vol. 91, pp. 2587-2591, March 1994 Biochemistry RanGAP1 induces GTPase activity of nuclear Ras-related Ran (GTPase-activating protein/RCCl/TC4/G2 checkpoint) F. RALF BISCHOFF*t, CHRISTIAN KLEBEt, JURGEN KRETSCHMER*, ALFRED WITrINGHOFERt, AND HERWIG PONSTINGL* *Division for Molecular Biology of Mitosis, German Cancer Research Center, D-69120 Heidelberg, Federal Republic of Germany; and *Abteilung Strukturelle Biologie, Max-Planck-Institut ffr Molekulare Physiologie, D-44139 Dortmund, Federal Republic of Germany Communicated by Hans Neurath, December 3, 1993 ABSTRACT The nuclear Ras-related protein Ran binds DMAE-650/M (Merck; Superformance, 26 x 115 mm) in 20 guanine nucleotide and is involved in cell cycle regulation. mM Bis-Tris-propane HCl, pH 7.0/1 mM DTT with a linear Models of the signal pathway predict Ran to be active as gradient of NaCl from 0.05 M to 1 M at a flow rate of 5 Ran GTP at the initiation of S phase upon activation by the ml/min. Fractions containing RanGAP were pooled and nucleotide exchange factor RCC1 and to be inactivated for the immediately applied to a hydroxylapatite column (Merck; onset of mitosis by hydrolysis of bound GTP. Here a nuclear Superformance, 10 x 150 mm) in 20 mM potassium phos- homodimeric 65-kDa protein, RanGAPl, is described, which phate, pH 7.0/1 mM DTT, with a linear gradient from 20 mM we believe to be the immediate antagonist of RCC1. It was to 1 M phosphate at a flow rate of 2 ml/min. To fractions purified from HeLa cell lysates and induces GTPase activity of containing RanGAP, ammonium sulfate in 20 mM Bis-Tris- Ran, but not Ras, by more than 3 orders of magnitude.
    [Show full text]
  • Gene Expression Profiling of Corpus Luteum Reveals the Importance Of
    bioRxiv preprint doi: https://doi.org/10.1101/673558; this version posted February 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Gene expression profiling of corpus luteum reveals the 2 importance of immune system during early pregnancy in 3 domestic sheep. 4 Kisun Pokharel1, Jaana Peippo2 Melak Weldenegodguad1, Mervi Honkatukia2, Meng-Hua Li3*, Juha 5 Kantanen1* 6 1 Natural Resources Institute Finland (Luke), Jokioinen, Finland 7 2 Nordgen – The Nordic Genetic Resources Center, Ås, Norway 8 3 College of Animal Science and Technology, China Agriculture University, Beijing, China 9 * Correspondence: MHL, [email protected]; JK, [email protected] 10 Abstract: The majority of pregnancy loss in ruminants occurs during the preimplantation stage, which is thus 11 the most critical period determining reproductive success. While ovulation rate is the major determinant of 12 litter size in sheep, interactions among the conceptus, corpus luteum and endometrium are essential for 13 pregnancy success. Here, we performed a comparative transcriptome study by sequencing total mRNA from 14 corpus luteum (CL) collected during the preimplantation stage of pregnancy in Finnsheep, Texel and F1 15 crosses, and mapping the RNA-Seq reads to the latest Rambouillet reference genome. A total of 21,287 genes 16 were expressed in our dataset. Highly expressed autosomal genes in the CL were associated with biological 17 processes such as progesterone formation (STAR, CYP11A1, and HSD3B1) and embryo implantation (eg.
    [Show full text]
  • T-Cell Receptor (TCR) Signaling Promotes the Assembly of Ranbp2
    RESEARCH ARTICLE T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1- SUMO1/Ubc9 nuclear pore subcomplex via PKC--mediated phosphorylation of RanGAP1 Yujiao He1, Zhiguo Yang1†, Chen-si Zhao1†, Zhihui Xiao1†, Yu Gong1, Yun-Yi Li1, Yiqi Chen1, Yunting Du1, Dianying Feng1, Amnon Altman2, Yingqiu Li1* 1MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China; 2Center for Cancer Immunotherapy, La Jolla Institute for Immunology, La Jolla, United States Abstract The nuclear pore complex (NPC) is the sole and selective gateway for nuclear transport, and its dysfunction has been associated with many diseases. The metazoan NPC subcomplex RanBP2, which consists of RanBP2 (Nup358), RanGAP1-SUMO1, and Ubc9, regulates the assembly and function of the NPC. The roles of immune signaling in regulation of NPC remain poorly understood. Here, we show that in human and murine T cells, following T-cell receptor (TCR) stimulation, protein kinase C-q (PKC-q) directly phosphorylates RanGAP1 to facilitate RanBP2 subcomplex assembly and nuclear import and, thus, the nuclear translocation of AP-1 transcription *For correspondence: factor. Mechanistically, TCR stimulation induces the translocation of activated PKC-q to the NPC, 504 506 [email protected] where it interacts with and phosphorylates RanGAP1 on Ser and Ser . RanGAP1 phosphorylation increases its binding affinity for Ubc9, thereby promoting sumoylation of RanGAP1 †These authors contributed and, finally, assembly of the RanBP2 subcomplex. Our findings reveal an unexpected role of PKC-q equally to this work as a direct regulator of nuclear import and uncover a phosphorylation-dependent sumoylation of Competing interests: The RanGAP1, delineating a novel link between TCR signaling and assembly of the RanBP2 NPC authors declare that no subcomplex.
    [Show full text]
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST-CNRS Gene Section Review RANBP2 (RAN binding protein 2) Erica Di Cesare, Patrizia Lavia Institute of Biology, Molecular Medicine and NanoBiotechnology (IBMN), National Research Council (CNR), c/o La Sapienza University, via degli Apuli 4, 00185 Rome, Italy (ED, PL) Published in Atlas Database: August 2014 Online updated version : http://AtlasGeneticsOncology.org/Genes/RANBP2ID483.html Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/62145/08-2014-RANBP2ID483.pdf DOI: 10.4267/2042/62145 This article is an update of : Di Cesare E, Lavia P. RANBP2 (RAN binding protein 2). Atlas Genet Cytogenet Oncol Haematol 2015;19(6) Huret JL, Senon S. RANBP2 (RAN binding protein). Atlas Genet Cytogenet Oncol Haematol 2003;7(4) This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology alternative splicing variants (AceView; NCBI; Abstract GeneCards). Review on RANBP2, with data on DNA/RNA, on Transcription the protein encoded and where the gene is implicated. RANBP2 mRNA transcription is widespread in many though not all tissues (Fauser et al., 2001). In the mouse genome, the Ranbp2 promoter region lies Identity in a CpG island, typical of "housekeeping" gene Other names: ADANE, ANE1, NUP358 promoters and potentially subjected to epigenetic regulation. In silico analysis of the human RANBP2 HGNC (Hugo): RANBP2 gene promoter has identified potential binding sites Location: 2q12.3 for cell cycle- and cell proliferation-dependent Note transcription factors, some validated in chromatin The human RANBP2 gene lies within a immunoprecipitation (ChIP) assays (e.g., c-Fos, AP1 recombination "hot spot" genomic region on Chr and others) (GeneCards).
    [Show full text]
  • Regulation of Bcl11b by Post-Translational Modifications
    AN ABSTRACT OF THE THESIS OF Xiao Liu for the degree of Master of Science in Pharmacy presented on June 3, 2011. Title: REGULATION OF BCL11B BY POST-TRANSLATIONAL MODIFICATIONS. Abstract approved Mark E. Leid Bcl11b (B-cell lymphoma/leukemia 11b), also known as Ctip2 (Chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2), is a C2H2 zinc finger transcriptional regulatory protein, which is an essential protein for post-natal life in the mouse and plays crucial roles in the development, and presumably function, of several organ systems, including the central nervous, immune, craniofacial formation and cutaneous/skin systems. Moreover, inactivation of Bcl11b has been implicated in the etiology of lymphoid malignancies, suggesting that Bcl11b may function as a tumor suppressor. Bcl11b was originally identified as a protein that interacted directly with the orphan nuclear receptor COUP-TF2. Later studies revealed that this C2H2 zinc finger protein can bind DNA directly in a COUP-independent manner, and it has been studied mostly as a transcription repressor. In T cells, gene repression mediated by Bcl11b involves the recruitment of class I HDACs, HDAC1 and HDAC2, within the context of the Nucleosome Remodeling and Deacetylation (NuRD) complex. The hypothesis that Bcl11b functions as a transcriptional repressor has been supported by transcriptome analyses in mouse T cells and human neuroblastoma cells. However, approximately one- third of the genes that were dysregulated in the double positive (DP) cells of Bcl11b-null mice were down-regulated relative to control T cells, suggesting that Bcl11b may act as a transcriptional activator in some promoter and/or cell contexts.
    [Show full text]
  • Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance
    biomolecules Review Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance Catherine Gough and Ari Sadanandom * Department of Biosciences, Durham University, Stockton Road, Durham DH1 3LE, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-1913341263 Abstract: Plants are constantly threatened by pathogens, so have evolved complex defence signalling networks to overcome pathogen attacks. Post-translational modifications (PTMs) are fundamental to plant immunity, allowing rapid and dynamic responses at the appropriate time. PTM regulation is essential; pathogen effectors often disrupt PTMs in an attempt to evade immune responses. Here, we cover the mechanisms of disease resistance to pathogens, and how growth is balanced with defence, with a focus on the essential roles of PTMs. Alteration of defence-related PTMs has the potential to fine-tune molecular interactions to produce disease-resistant crops, without trade-offs in growth and fitness. Keywords: post-translational modifications; plant immunity; phosphorylation; ubiquitination; SUMOylation; defence Citation: Gough, C.; Sadanandom, A. 1. Introduction Understanding and Exploiting Plant growth and survival are constantly threatened by biotic stress, including plant Post-Translational Modifications for pathogens consisting of viruses, bacteria, fungi, and chromista. In the context of agriculture, Plant Disease Resistance. Biomolecules crop yield losses due to pathogens are estimated to be around 20% worldwide in staple 2021, 11, 1122. https://doi.org/ crops [1]. The spread of pests and diseases into new environments is increasing: more 10.3390/biom11081122 extreme weather events associated with climate change create favourable environments for food- and water-borne pathogens [2,3]. Academic Editors: Giovanna Serino The significant estimates of crop losses from pathogens highlight the need to de- and Daisuke Todaka velop crops with disease-resistance traits against current and emerging pathogens.
    [Show full text]
  • Progress in the Discovery of Small Molecule Modulators of Desumoylation
    Curr. Issues Mol. Biol. (2020) 35: 17-34. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation Shiyao Chen, Duoling Dong, Weixiang Xin and Huchen Zhou* School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.017 Abstract protein–protein interactions, gene transcription, SUMOylation and DeSUMOylation are reversible genome integrity, and DNA replication and repair protein post-translational modifcation (PTM) (Wilkinson and Henley, 2010; Vierstra, 2012; processes involving small ubiquitin-like modifer Bailey et al., 2016). In 1995, Meluh and Koshland (SUMO) proteins. Tese processes have indis- (1995) identifed Smt3 in Saccharomyces cerevi- pensable roles in various cellular processes, such siae, which is the earliest report within this fled. as subcellular localization, gene transcription, and Two years later, based on the sequence similarity DNA replication and repair. Over the past decade, between ubiquitin and a new 11.5-kDa protein, increasing atention has been given to SUMO- ubiquitin/SMT3, the name SUMO was formally related pathways as potential therapeutic targets. proposed for the frst time (Mahajan et al., 1997). Te Sentrin/SUMO-specifc protease (SENP), Although SUMO modifcation is closely which is responsible for deSUMOylation, has related to the progression of various diseases, such been proposed as a potential therapeutic target as cancers and cardiac disorders, it has aroused in the treatment of cancers and cardiac disorders. increasing atention as a potential therapeutic target Unfortunately, no SENP inhibitor has yet reached in recent years, especially concerning the Sentrin/ clinical trials. In this review, we focus on advances SUMO-specifc protease (SENP), which is the key in the development of SENP inhibitors in the past regulator of deSUMOylation.
    [Show full text]
  • Ginkgolic Acid, a Sumoylation Inhibitor, Promotes Adipocyte
    www.nature.com/scientificreports OPEN Ginkgolic acid, a sumoylation inhibitor, promotes adipocyte commitment but suppresses Received: 25 October 2017 Accepted: 15 January 2018 adipocyte terminal diferentiation Published: xx xx xxxx of mouse bone marrow stromal cells Huadie Liu1,2, Jianshuang Li2, Di Lu2, Jie Li1,2, Minmin Liu 3, Yuanzheng He4, Bart O. Williams2, Jiada Li1 & Tao Yang 2 Sumoylation is a post-translational modifcation process having an important infuence in mesenchymal stem cell (MSC) diferentiation. Thus, sumoylation-modulating chemicals might be used to control MSC diferentiation for skeletal tissue engineering. In this work, we studied how the diferentiation of mouse bone marrow stromal cells (mBMSCs) is afected by ginkgolic acid (GA), a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT). Our results show that GA promoted the diferentiation of mBMSCs into adipocytes when cultured in osteogenic medium. Moreover, mBMSCs pre-treated with GA showed enhanced pre-adipogenic gene expression and were more efciently diferentiated into adipocytes when subsequently cultured in the adipogenic medium. However, when GA was added at a later stage of adipogenesis, adipocyte maturation was markedly inhibited, with a dramatic down-regulation of multiple lipogenesis genes. Moreover, we found that the efects of garcinol, a HAT inhibitor, difered from those of GA in regulating adipocyte commitment and adipocyte maturation of mBMSCs, implying that the GA function in adipogenesis is likely through its activity as a sumoylation inhibitor, not as a HAT inhibitor. Overall, our studies revealed an unprecedented role of GA in MSC diferentiation and provide new mechanistic insights into the use of GA in clinical applications.
    [Show full text]
  • Genome-Wide Identification of Genes Regulating DNA Methylation Using Genetic Anchors for Causal Inference
    bioRxiv preprint doi: https://doi.org/10.1101/823807; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genome-wide identification of genes regulating DNA methylation using genetic anchors for causal inference Paul J. Hop1,2, René Luijk1, Lucia Daxinger3, Maarten van Iterson1, Koen F. Dekkers1, Rick Jansen4, BIOS Consortium5, Joyce B.J. van Meurs6, Peter A.C. ’t Hoen 7, M. Arfan Ikram8, Marleen M.J. van Greevenbroek9,10, Dorret I. Boomsma11, P. Eline Slagboom1, Jan H. Veldink2, Erik W. van Zwet12, Bastiaan T. Heijmans1* 1 Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, 2333 ZC, The Netherlands 2 Department of Neurology, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht University, Utrecht 3584 CG, Netherlands 3 Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZC, The Netherlands 4 Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, 1081 HV, The Netherlands 5 Biobank-based Integrated Omics Study Consortium. For a complete list of authors, see the acknowledgements. 6 Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands. 7 Centre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University
    [Show full text]